| Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients with Rheumatoid Arthritis. Mäki-Petäjä KM, E M, C J, J FR, O AJ, H FC, R JH, W IB. Circulation, 2012 | 248 | 2012 |
| Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist AL Brame, JJ Maguire, P Yang, A Dyson, R Torella, J Cheriyan, M Singer, ... Hypertension 65 (4), 834-840, 2015 | 169 | 2015 |
| Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis M Elkhawad, JHF Rudd, L Sarov-Blat, G Cai, R Wells, LC Davies, ... JACC: Cardiovascular Imaging 5 (9), 911-922, 2012 | 162 | 2012 |
| Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor AL Lazaar, L Yang, RL Boardley, NS Goyal, J Robertson, SJ Baldwin, ... British journal of clinical pharmacology 81 (5), 971-979, 2016 | 155 | 2016 |
| Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: a randomised controlled trial PR Gajendragadkar, A Hubsch, KM Mäki-Petäjä, M Serg, IB Wilkinson, ... PloS one 9 (6), e99070, 2014 | 153 | 2014 |
| Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure G Pucci, J Cheriyan, A Hubsch, SS Hickson, PR Gajendragadkar, ... Journal of hypertension 31 (1), 77-85, 2013 | 145 | 2013 |
| Inhibition of p38 mitogen-activated protein kinase improves nitric oxide–mediated vasodilatation and reduces inflammation in hypercholesterolemia J Cheriyan, AJ Webb, L Sarov-Blat, M Elkhawad, SML Wallace, ... Circulation 123 (5), 515-523, 2011 | 131 | 2011 |
| Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans IS Mackenzie, KM Maki-Petaja, CM McEniery, YP Bao, SM Wallace, ... Arteriosclerosis, thrombosis, and vascular biology 25 (9), 1891-1895, 2005 | 126 | 2005 |
| Clinical pharmacokinetics, safety, and tolerability of a novel, first-in-class TRPV4 ion channel inhibitor, GSK2798745, in healthy and heart failure subjects N Goyal, P Skrdla, R Schroyer, S Kumar, D Fernando, A Oughton, ... American Journal of Cardiovascular Drugs 19 (3), 335-342, 2019 | 107 | 2019 |
| Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease M Fisk, PR Gajendragadkar, KM Mäki-Petäjä, IB Wilkinson, J Cheriyan American Journal of Cardiovascular Drugs 14, 155-165, 2014 | 107 | 2014 |
| Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind … TX Zhao, M Kostapanos, C Griffiths, EL Arbon, A Hubsch, F Kaloyirou, ... BMJ open 8 (9), e022452, 2018 | 98 | 2018 |
| Mechanisms of vascular dysfunction in COPD and effects of a novel soluble epoxide hydrolase inhibitor in smokers L Yang, J Cheriyan, DD Gutterman, RJ Mayer, Z Ament, JL Griffin, ... Chest 151 (3), 555-563, 2017 | 83 | 2017 |
| The accuracy of central SBP determined from the second systolic peak of the peripheral pressure waveform SS Hickson, M Butlin, FA Mir, J Graggaber, J Cheriyan, F Khan, AA Grace, ... Journal of hypertension 27 (9), 1784-1788, 2009 | 83 | 2009 |
| The role of epoxyeicosatrienoic acids in the cardiovascular system L Yang, K Mäki‐Petäjä, J Cheriyan, C McEniery, IB Wilkinson British journal of clinical pharmacology 80 (1), 28-44, 2015 | 77 | 2015 |
| [Pyr1]Apelin-13(1–12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr1]Apelin-13 P Yang, RE Kuc, AL Brame, A Dyson, M Singer, RC Glen, J Cheriyan, ... Frontiers in Neuroscience 11, 92, 2017 | 74 | 2017 |
| Quantification of lung PET images: challenges and opportunities DL Chen, J Cheriyan, ER Chilvers, G Choudhury, C Coello, M Connell, ... Journal of Nuclear Medicine 58 (2), 201-207, 2017 | 74 | 2017 |
| Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction KM Mäki-Petäjä, J Cheriyan, AD Booth, FC Hall, J Brown, SML Wallace, ... International journal of cardiology 129 (3), 399-405, 2008 | 74 | 2008 |
| Surrogate markers of cardiovascular risk and chronic obstructive pulmonary disease: a large case-controlled study M Fisk, CM McEniery, N Gale, K Mäki-Petäjä, JR Forman, M Munnery, ... Hypertension 71 (3), 499-506, 2018 | 65 | 2018 |
| The role of the autonomic nervous system in the regulation of aortic stiffness KM Mäki-Petäjä, SML Barrett, SV Evans, J Cheriyan, CM McEniery, ... Hypertension 68 (5), 1290-1297, 2016 | 65 | 2016 |
| Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects–a randomized, double‐blind, placebo‐controlled study J Ellis, A van Maurik, L Fortunato, S Gisbert, K Chen, A Schwartz, ... British journal of clinical pharmacology 85 (2), 304-315, 2019 | 44 | 2019 |
Kaisa Maki-PetajaUniversity of CambridgeVerified email at cam.ac.uk
